(Q39022171)

8 September 2017

Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL. (English)

1 reference

8 September 2017

Stéphane Bolduc

1

1 reference

8 September 2017

Louis Lacombe

2

1 reference

8 September 2017

Alain Naud

3

1 reference

8 September 2017

Mireille Grégoire

4

1 reference

8 September 2017

Yves Fradet

5

1 reference

8 September 2017

Roland R Tremblay

6

1 reference

8 September 2017

1 November 2007

1 reference

Canadian Urological Association journal

8 September 2017

1 reference

8 September 2017

1

1 reference

8 September 2017

4

1 reference

8 September 2017

377-381

1 reference

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

8 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

Influence of digital rectal massage on urinary prostate-specific antigen: interest for the detection of local recurrence after radical prostatectomy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

Extraprostatic production of prostate specific antigen is under hormonal control.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

Postcoital detection of a male-specific semen protein. Application to the investigation of rape

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2422995

The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen

21 August 2018

1 reference

12 December 2020

Urinary prostate specific antigen: is the clinical use likely?

1 reference

12 December 2020

Significance of prostatic acid phosphatase, gamma-seminoprotein and prostatic specific antigen in the urine. First report: the measurement of PAP, gamma-Sm and PA in the urine of patients with prostatic diseases

1 reference

12 December 2020

Excretion of three major prostatic secretory proteins in the urine of normal men and patients with benign prostatic hypertrophy or prostate cancer

1 reference

12 December 2020

Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives

1 reference

12 December 2020

Beta2-Microglobulin, Carcinoembryonic Antigen and Prostatic Acid Phosphatase in Split Ejaculates and Urine Voided Before and After Massage of the Prostate

1 reference

12 December 2020

Urinary prostate specific antigen levels after radical prostatectomy

1 reference

12 December 2020

Prostate-Specific Antigen in Urine

1 reference

12 December 2020

An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands

1 reference

12 December 2020

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer

1 reference

12 December 2020

Serum-to-urinary prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer

1 reference

12 December 2020

Serum-to-urinary prostate specific antigen ratio: its impact in distinguishing prostate cancer when serum prostate specific antigen level is 4 to 10 ng./ml

1 reference

12 December 2020

Identifiers

0 references

1 reference

8 September 2017

PubMed publication ID

18542821

1 reference